Literature DB >> 6021211

The state of copper in human serum: evidence for an amino acid-bound fraction.

P Z Neumann, A Sass-Kortsak.   

Abstract

In addition to copper bound to ceruloplasmin and to albumin, there is a third small fraction of copper in human serum that is bound to amino acids. The amino acid-bound fraction of copper is in equilibrium with albumin-bound copper, and both fractions are probably in equilibrium with ionic copper. Of the 23 amino acids that are known to be in human serum, a substantial number were shown (in physiological concentrations) to compete effectively with albumin for the binding of copper. In this respect, histidine had the most marked effect followed by glutamine, threonine, cystine, and others. The effect of the combined presence of 23 amino acids on the state of copper in human serum could not be explained on the basis of their individual abilities to compete with albumin for the binding of copper. It is suggested that copper may also be present in serum in the form of mixed amino acid-copper complexes consisting of one atom of copper and two different amino acids. Under normal conditions, histidine is the amino acid primarily involved in the formation of mixed amino acid-copper complexes in serum. In combination with histidine and copper, threonine, glutamine, and asparagine are the other amino acids that are most likely to be the third members of these mixed complexes. The first binding site for copper on human albumin is different from subsequent ones in that its binding affinity to copper is much higher. We propose that the amino acid-bound fraction of copper in serum may have a physiological role in the biological transport of copper.

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 6021211      PMCID: PMC442048          DOI: 10.1172/JCI105566

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  10 in total

Review 1.  COPPER METABOLISM IN NORMAL SUBJECTS.

Authors:  G E Cartwright; M M Wintrobe
Journal:  Am J Clin Nutr       Date:  1964-04       Impact factor: 7.045

2.  COMPARISON OF CUPRIC ION-BINDING SITES IN MYOGLOBIN DERIVATIVES AND SERUM ALBUMIN.

Authors:  E BRESLOW
Journal:  J Biol Chem       Date:  1964-10       Impact factor: 5.157

3.  Copper metabolism.

Authors:  I H SCHEINBERG; I STERNLIEB
Journal:  Pharmacol Rev       Date:  1960-09       Impact factor: 25.468

4.  Serum gamma globulin levels in normal infants.

Authors:  O ORLANDINI; A SASS-KORTSAK; J H EBBS
Journal:  Pediatrics       Date:  1955-11       Impact factor: 7.124

5.  The free amino acids of human blood plasma.

Authors:  W H STEIN; S MOORE
Journal:  J Biol Chem       Date:  1954-12       Impact factor: 5.157

6.  Studies on copper metabolism. IX. The transportation of copper in blood.

Authors:  C J GUBLER; M E LAHEY; G E CARTWRIGHT; M M WINTROBE
Journal:  J Clin Invest       Date:  1953-05       Impact factor: 14.808

7.  Micro-determination of copper in biological material.

Authors:  A Eden; H H Green
Journal:  Biochem J       Date:  1940-09       Impact factor: 3.857

8.  THE INCORPORATION OF COPPER INTO CERULOPLASMIN IN VIVO: STUDIES WITH COPPER AND COPPER.

Authors:  I Sternlieb; A G Morell; W D Tucker; M W Greene; I H Scheinberg
Journal:  J Clin Invest       Date:  1961-10       Impact factor: 14.808

9.  The influence of amino acids on copper uptake by rat liver slices.

Authors:  D I Harris; A Sass-Kortsak
Journal:  J Clin Invest       Date:  1967-04       Impact factor: 14.808

10.  Metabolism of copper in Wilson's disease and in normal subjects; studies with Cu-64.

Authors:  C J EARL; M J MOULTON; B SELVERSTONE
Journal:  Am J Med       Date:  1954-08       Impact factor: 4.965

  10 in total
  28 in total

1.  Calculating the geometry and Raman spectrum of physiological bis(L-histidinato)copper(II): an assessment of DFT functionals for aqueous and isolated systems.

Authors:  Jasmina Sabolović; Michael Ramek; Marijana Marković
Journal:  J Mol Model       Date:  2017-09-26       Impact factor: 1.810

2.  Ab initio modelling of the structure and redox behaviour of copper(I) bound to a His-His model peptide: relevance to the beta-amyloid peptide of Alzheimer's disease.

Authors:  Duilio F Raffa; Gail A Rickard; Arvi Rauk
Journal:  J Biol Inorg Chem       Date:  2006-09-30       Impact factor: 3.358

3.  Synthesis of the native copper(II)-transport site of human serum albumin and its copper(II)-binding properties.

Authors:  K S Iyer; S J Lau; S H Laurie; B Sarkar
Journal:  Biochem J       Date:  1978-01-01       Impact factor: 3.857

4.  Synthesis and evaluation of [64Cu]PSMA-617 targeted for prostate-specific membrane antigen in prostate cancer.

Authors:  Can Cui; Masayuki Hanyu; Akiko Hatori; Yiding Zhang; Lin Xie; Tomoya Ohya; Masami Fukada; Hisashi Suzuki; Kotaro Nagatsu; Cuiping Jiang; Rui Luo; Guoqiang Shao; Mingrong Zhang; Feng Wang
Journal:  Am J Nucl Med Mol Imaging       Date:  2017-04-15

Review 5.  Copper in brain.

Authors:  R M Nalbandyan
Journal:  Neurochem Res       Date:  1983-10       Impact factor: 3.996

6.  Relationship of secreted mucus to copper and acid toxicity in rainbow trout.

Authors:  T G Miller; W C Mackay
Journal:  Bull Environ Contam Toxicol       Date:  1982-01       Impact factor: 2.151

7.  Comparison of pathways of copper metabolism in aorta and liver. A functional test of metallothionein.

Authors:  J E Balthrop; C T Dameron; E D Harris
Journal:  Biochem J       Date:  1982-05-15       Impact factor: 3.857

8.  Importance of amino acids on vasopressin-stimulated water flow.

Authors:  C P Carvounis; G Carvounis; B J Wilk
Journal:  J Clin Invest       Date:  1985-08       Impact factor: 14.808

9.  Intestinal administration of copper and its transient release into venous rat blood serum concomitantly with metallothionein.

Authors:  H J Hartmann; K Felix; W Nagel; U Weser
Journal:  Biometals       Date:  1993       Impact factor: 2.949

Review 10.  Copper in the brain and Alzheimer's disease.

Authors:  Ya Hui Hung; Ashley I Bush; Robert Alan Cherny
Journal:  J Biol Inorg Chem       Date:  2009-10-28       Impact factor: 3.358

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.